Hospitals could be facing lower reimbursement for non-drug items and services, 340B drugs, excepted off-campus provider-based department (PBD) services, as well as additional price transparency and prior authorization requirements, according to CMS’ 2027 Outpatient Prospective Payment System (OPPS) proposed rule.